Jump to content

Recommended Posts

Posted

Picture1.jpg.64c6ad2e8aeef9d5944770bf6875d3b2.jpg

JUST ARRIVED. The Emirates flight carrying 547,100 doses of the AstraZeneca Covid-19 vaccine, donated by Poland, lands at the Ninoy Aquino International Airport Terminal 3 in Pasay City on Sunday (Nov. 28, 2021). It was the first vaccine donation from the Polish government. (PNA photo by Avito Dalan)

 

MANILA – The government is open to entering into tripartite deals for the second wave procurement of coronavirus jabs, but vaccine makers prefer bilateral negotiations, National Task Force (NTF) Against Covid-19 chief implementer Secretary Carlito Galvez Jr. said on Sunday.

 

In a virtual presser, Galvez acknowledged the positive results of tripartite agreements with the private sector and local government units (LGUs) but vaccine manufacturers they have dealt with favor bilateral talks due to challenges in shipping small volumes of Covid-19 jabs.

 

" The concentration of the manufacturers as of now is they want to deal with the government for bulk orders of vaccines. Unlike in tripartite, they are having difficulties in dealing with only 20,000 or 30,000 doses," he said.

 

He advised LGUs and the private sector to focus their budget next year on procuring ancillary supplies such as syringes and cold chain storage equipment.

 

" They can buy syringes or cold chain storage and the national government will take care of vaccine procurement," he said.

 

Galvez said most LGUs trust the national government is capable of acquiring larger volumes of Covid-19 vaccines. (PNA)

 

Join our 3 x a week Philippines News, Travel and Expat information newsletter and keep up to date. https://aseannow.com/newsletter.php

 

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.



×
×
  • Create New...